Barclays 2007 Annual Report Download - page 160

Corporate governance
Remuneration report
Directors: interests in ordinary shares of Barclays PLC a
At 1st January 2007bAt 31st December 2007
Non- Non-
Beneficial beneficial Beneficial beneficial
Group Chairman
Marcus Agius 15,000 – 86,136 –
Executive Directors
John Varley 375,053 – 470,650 –
Robert E Diamond Jre2,531,582 – 3,402,192 –
Gary Hoffman 319,186 – 431,761 –
Chris Lucasf––38,003 –
Frits Seegers d4,319 – 699,870 –
Non-executive Directorsc
David Booth g––50,374 –
Sir Richard Broadbent 8,092 – 14,026 –
Leigh Clifford 5,219 – 18,872 –
Fulvio Conti 2,538 – 10,067 –
Dr Danie Cronjéd3,547 – 5,146 –
Professor Dame Sandra Dawson 9,953 – 12,040 –
Sir Andrew Likierman 5,441 – 8,137 –
Sir Nigel Rudd 51,117 – 84,843 –
Stephen Russell 18,661 – 21,054 –
Sir John Sunderland 10,054 – 31,658 –
158 Barclays PLC Annual Report 2007
Notes
aBeneficial interests in the table above represent shares held by Directors who were on
the Board as at 31st December 2007, either directly or through a nominee, their spouse
and children under 18. They include any interests held through Sharepurchase, but
do not include any awards under ESAS, ISOP, PSP, ESOS and Sharesave. The beneficial
interests in ordinary shares of Barclays PLC held by all Directors as shown in the table
above amounted in aggregate to 5,384,829 ordinary shares of Barclays PLC as at
31st December 2007 and 5,398,797 ordinary shares of Barclays PLC as at 27th February
2008 (which amounted to less than 1% of Barclays PLC ordinary share capital outstanding
as at 31st December 2007 and 27th February 2008 respectively). Note 42 provides
further information on Directors’ and Officers’ shareholdings. As at 31st December
2007, the executive Directors, together with other senior executives, were potential
beneficiaries in respect of a total of 207,685,698 Barclays PLC ordinary shares
(1st January 2007: 165,645,889) held by the trustees of the Barclays EBTs. As at
27th February 2008, a total of 218,235,925 shares were held by the trustees.
bOr date appointed to the Board if later.
cOn 19th February 2008, the non-executive Directors acquired ordinary shares pursuant
to arrangements under which part of each non-executive Director’s fee is used to buy
shares in Barclays. Barclays shares were acquired by each non-executive Director as
follows: David Booth – 1,183; Sir Richard Broadbent – 1,487; Leigh Clifford – 1,312;
Fulvio Conti – 1,401; Dr Danie Cronjé – 1,270; Professor Dame Sandra Dawson –
1,485; Sir Andrew Likierman – 1,353; Sir Michael Rake – 204; Sir Nigel Rudd – 1,646;
Stephen Russell – 1,600; Sir John Sunderland – 1,231; Patience Wheatcroft – 169.
On 19th February 2008, Sir Michael Rake also acquired 1,100 ordinary shares in Barclays.
On 26th February 2008, Patience Wheatcroft acquired 1,200 ordinary shares in Barclays
and Sir Nigel Rudd sold 28,000 ordinary shares in Barclays and acquired 28,000 ordinary
shares in Barclays in PEP and ISA accounts. Except as described in this note, there
were no changes to the beneficial or non-beneficial interests of Directors in the period
31st December 2007 to 27th February 2008.
dAs at 1st January 2007, Frits Seegers and Dr Danie Cronjé held 1,000 and 101,577 shares
in Absa Group Limited respectively. As at 31st December 2007, Frits Seegers and Dr Danie
Cronjé held 1,000 and 101,577 shares in Absa Group Limited respectively. Dr Danie
Cronjé also held 7,500 non-cumulative, non-redeemable preference shares in Absa Bank
Limited as at 1st January 2007 and 11,700 such shares as at 31st December 2007.
eAs at 1st January 2007 and 31st December 2007, Robert E Diamond Jr held 200,000
‘A’ ordinary shares in Barclays Global Investors UK Holdings Limited.
fAppointed as an executive Director on 1st April 2007.
gAppointed as a non-executive Director on 1st May 2007.